ORIGINAL ARTICLESDebrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
References (35)
- et al.
Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine
J Biol Chem
(1990) - et al.
Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine
Lancet
(1985) - et al.
Debrisoquine metabolism in Parkinsonian patients treated with antihistamine drugs
Lancet
(1987) - et al.
Genetic analysis of cytochrome P450 gene loci
Methods Enzymol
(1991) - et al.
Detection of debrisoquine hydroxylation phenotypes
Lancet
(1990) - et al.
Etiology of Parkinson's disease
Lancet
(1983) - et al.
Inhibition of NADH-linked oxidation in brain mitochondria by MPP+, a metabolite of the neurotoxin MPTP
Life Sci
(1985) - et al.
4'-alkylated analogs of MPP + are potent inhibitors of mitochondrial respiration
Biochem Biophys Res Commun
(1990) - et al.
MPTP the neurotoxin inducing Parkinson's disease, is a potent inhibitor of human and rat P450 enzymes (P450bufl, P450db1) catalyzing debrisoquine 4-hydroxylation
Biochem Biophys Res Commun
(1987) - et al.
The genetic polymorphism of debrisoquine/ sparteine metabolism—clinical aspects
Pharmacol Ther
(1990)
Metabolic factors in cancer susceptibility
Cancer Surv
(1990)
The genetics of Parkinson's disease
Neurology
(1990)
Genetic susceptibility to Parkinson's disease
Neurology
(1991)
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population
J Med Genet
(1980)
Identification of the primary gene defect at the cytochrome P450 CYP2D6 locus
Nature
(1990)
The human CYP2D6 locus associated with a common genetic defect in drug oxidation: a G1943 to A base change in intron 3 of a mutant CYP2D6 allele results in an aberrrant 3' splice recognition site.
Am J Hum Genet
(1990)
Deletion of the entire CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism
Am J Hum Genet
(1991)
Cited by (0)
Copyright © 1992 Published by Elsevier Ltd.